Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease
Open Access
- 11 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 132 (6), 1545-1552
- https://doi.org/10.1093/brain/awp065
Abstract
Over 100 mutations in the myophosphorylase gene, which cause McArdle disease, are known. All these mutations have resulted in a complete block of muscle glycogenolysis, and accordingly, no genotype–phenotype correlation has been identified in this condition. We evaluated physiologic and genetic features of two patients with a variant form of McArdle disease, associated with unusually high exercise capacity. Physiologic findings were compared to those in 47 patients with typical McArdle disease, and 17 healthy subjects. Subjects performed an ischaemic forearm exercise test to assess lactate and ammonia production. Peak oxidative capacity (VO2max) and cardiac output were determined, using cycle ergometry as the exercise modality. The two patients with atypical McArdle disease carried common mutations on one allele (R50X and G205S), and novel splice mutations in introns 3 [IVS3-26A>G (c.425-26A>G)] and 5 [IVS5-601G>A (c.856-601G>A)] on the other allele. Plasma lactate after ischaemic exercise decreased in all typical McArdle patients, but increased in the two atypical McArdle patients (10% of that in healthy subjects). Peak workload and oxidative capacity were 2-fold higher in patients with atypical McArdle disease compared to typical McArdle patients. Oxygen uptake, relative to cardiac output, was severely impaired in the 47 patients with typical McArdle disease, and partially normalized in the milder affected McArdle patients. These findings identify the first distinct genotype-phenotype relationship in McArdle disease, and indicate that minimal myophosphorylase activity ameliorates the typical McArdle disease phenotype by augmenting muscle oxidative capacity. The milder form of McArdle disease provides important clues to the level of functional myophosphorylase needed to support muscle oxidative metabolism.Keywords
This publication has 44 references indexed in Scilit:
- Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacityJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?Neurology, 2008
- Randomized, placebo‐controlled, double‐blind pilot trial of ramipril in McArdle's diseaseMuscle & Nerve, 2007
- Genotype modulators of clinical severity in McArdle diseaseNeuroscience Letters, 2007
- Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase geneNeuroscience Letters, 2005
- Pharmacologic therapy for stop mutations: how much CFTR activity is enough?Current Opinion in Pulmonary Medicine, 2004
- A diagnostic cycle test for McArdle's diseaseAnnals of Neurology, 2003
- Ischemic exercise test: Failure to detect partial expression of Mcardle's diseaseMuscle & Nerve, 1987
- Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.JCI Insight, 1983
- Glycolysis in skeletal muscle regenerationExperimental Neurology, 1976